Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pedigree Analysis

Pedigree Analysis

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

S100A9 promotes inflammasome-dependent autoinflammation by blocking the degradation of SYK tyrosine kinase.

Journal of leukocyte biology·2025

Same author

Discovery of potent and selective inhibitors of human NLRP3 with a novel mechanism of action.

The Journal of experimental medicine·2025

Same author

Mevalonate kinase deficiency: an updated clinical overview and revision of the SHARE recommendations.

Frontiers in immunology·2024

Same author

Examination of antinuclear antibody staining patterns and titers in patients with childhood-onset systemic lupus erythematosus.

Lupus·2024

Same author

A case with systemic juvenile idiopathic arthritis treated with tofacitinib and rapamycin.

Rheumatology (Oxford, England)·2024

Same author

Long-term follow-up of anti-TNF treatment in adult and pediatric DADA2 patients: Insights from real-world data.

International journal of rheumatic diseases·2024

Search research articles

Related Experiment Video

Updated: May 9, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

Pediatric-onset Behçet disease.

Seza Ozen¹, Fehime K Eroglu

¹Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey. sezaozen@hacettepe.edu.tr

Current Opinion in Rheumatology

|July 23, 2013

Summary

This summary is machine-generated.

Recent research on Behçet disease highlights genetic links, particularly the IL23/IL17 pathway, and improved understanding of its varied clinical presentations. New biologics show promise for treatment-resistant cases.

More Related Videos

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia

Published on: January 19, 2022

Related Experiment Videos

Last Updated: May 9, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia

Published on: January 19, 2022

Area of Science:

Immunology
Genetics
Rheumatology

Background:

Behçet disease is a complex vasculitis with heterogeneous clinical manifestations.
Understanding its etiopathogenesis is challenging due to disease variability.

Purpose of the Study:

To review recent advancements in Behçet disease genetics and pathogenesis.
To analyze current clinical features and treatment approaches.

Main Methods:

Review of genome-wide association studies (GWAS).
Analysis of immunological studies focusing on cytokine pathways.
Evaluation of clinical studies, including pediatric cases and treatment outcomes.

Main Results:

GWAS confirm HLA-B51 association and highlight the IL23/IL17 pathway and IL10.
Immunological data support IL17's role in pathogenesis.
Clinical studies clarify vascular and CNS involvement; pediatric criteria need refinement.
New biologic drugs show efficacy in refractory Behçet disease.

Conclusions:

Identified pathways offer insights into pathogenesis and targeted therapies.
Disease heterogeneity complicates research; multicenter studies are crucial for conclusive results.
Improved classification criteria are needed, especially for pediatric Behçet disease.